Hologic will occupy two booths at this year's RSNA meeting to showcase the company's changing identity and its growing array of imaging products. One booth will feature only new technologies from each of the company's four divisions: Hologic Radiographic
Hologic will occupy two booths at this year's RSNA meeting to showcase the company's changing identity and its growing array of imaging products.
One booth will feature only new technologies from each of the company's four divisions: Hologic Radiographic Systems, which focuses on direct and general radiography; Lorad, specializing in digital and analog breast imaging and minimally invasive breast biopsy systems; Fluoroscan, which provides C-arm imaging devices for orthopedics and pain management; and Hologic Bone Densitometry Systems.
A second booth will feature a mix of new technologies and product lines from the four divisions.
Hologic and its divisions will display:
Hologic was established in 1986 as a developer, manufacturer, and marketer of proprietary x-ray and ultrasound bone analyzer systems. It is shifting focus in the hope it will become a leading provider of comprehensive radiographic solutions. If recent moves are any indication, that goal may not be unrealistic.
Hologic acquired Fluoroscan Imaging Systems in 1996 and Direct Radiography Corp. (DRC) three years later. Earlier this year the company completed its hat trick by acquiring the U.S. assets of Trex Medical, including the Lorad, Continental, and Bennett x-ray product lines.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.